Skip to main content
Back to SV Angel

SV Angel's Life Science Portfolio

Browse 8 Life Science companies funded by SV Angel. See funding amounts, founder contacts, and investment details.

Life Science Companies
8
Total Funding in Life Science
$246.5M

Life Science Portfolio Companies (8)

Export
E-CommerceEnterprise SoftwareLife ScienceProcurement

The world’s leading solution for consolidating lab communication, inventory management, and lab supply purchasing.

Hayward, United States
April 2026
Debt Financing

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMarket Research

Phylo provides an integrated workspace with AI-assisted tools to support planning, execution, and review of biological research.

South San Francisco, United States
February 2026
$13.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsLife Science

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

San Francisco, United States
April 2024
$95.0M
Corporate Round

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

San Francisco, United States
August 2023
$4.0M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

San Francisco, United States
January 2023
$9.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Los Angeles, United States
April 2022
$80.0M
Series B

Founder Contacts

41,000+ verified contacts

AppsHealth CareHealth DiagnosticsLife ScienceMobile AppsProduct Management

Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.

Cambridge, United States
April 2022
$45.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical

A comprehensive platform and product suite for advanced therapeutics.

Brisbane, United States
January 2022
Series A

Founder Contacts

41,000+ verified contacts

Explore SV Angel's Full Portfolio

View all companies funded by SV Angel across every industry and funding stage.

View Full SV Angel Portfolio